We assessed the relationship between MRP1 mRNA levels and other important clinical characteristics such as cytogenetic subgroups and FAB subtypes, and we showed that high expression of MRP1 was correlated with FAB subtype and cytogenetic risk groups among AML patients. Here, ABCC1 is linked to acute myeloid leukemia.